Inhibikase Therapeutics Inc (NAS:IKT)
$ 1.17 0.0097 (0.84%) Market Cap: 8.94 Mil Enterprise Value: 926,000.00 PE Ratio: 0 PB Ratio: 1.69 GF Score: 41/100